{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:22:29Z","timestamp":1793830949364,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10549-018-4661-x","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T13:23:25Z","timestamp":1516022605000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer"],"prefix":"10.1007","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2751-2332","authenticated-orcid":false,"given":"Florentia","family":"Fostira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Saloustros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Apostolou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromahi","family":"Vagena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Kalfakakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tryfonopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassileios","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drakoulis","family":"Yannoukakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Konstantopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"issue":"12","key":"4661_CR1","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1200\/JCO.2009.25.5729","volume":"28","author":"LA Korde","year":"2010","unstructured":"Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, Bartlett JM, Gelmon K, Nahleh Z, Bergh J, Cutuli B, Pruneri G, McCaskill-Stevens W, Gralow J, Hortobagyi G, Cardoso F (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28(12):2114\u20132122. https:\/\/doi.org\/10.1200\/JCO.2009.25.5729","journal-title":"J Clin Oncol"},{"issue":"1","key":"4661_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","volume":"14","author":"JR Weiss","year":"2005","unstructured":"Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Biomark Prev 14(1):20\u201326","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4661_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx651","author":"F Cardoso","year":"2017","unstructured":"Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schroder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litiere S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH (2017) Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program. Ann Oncol. https:\/\/doi.org\/10.1093\/annonc\/mdx651","journal-title":"Ann Oncol"},{"issue":"20","key":"4661_CR4","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jnci\/djn329","volume":"100","author":"LA Brinton","year":"2008","unstructured":"Brinton LA, Richesson DA, Gierach GL, Lacey JV Jr, Park Y, Hollenbeck AR, Schatzkin A (2008) Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 100(20):1477\u20131481. https:\/\/doi.org\/10.1093\/jnci\/djn329","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"4661_CR5","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/jnci\/djm203","volume":"99","author":"YC Tai","year":"2007","unstructured":"Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811\u20131814. https:\/\/doi.org\/10.1093\/jnci\/djm203","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"4661_CR6","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"Breast Cancer Linkage C","year":"1999","unstructured":"Breast Cancer Linkage C (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310\u20131316","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4661_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR, Consortium CH-BC (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31(1):55\u201359. https:\/\/doi.org\/10.1038\/ng879","journal-title":"Nat Genet"},{"issue":"2","key":"4661_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-008-0162-7","volume":"116","author":"M Wasielewski","year":"2009","unstructured":"Wasielewski M, den Bakker MA, van den Ouweland A, Meijer-van Gelder ME, Portengen H, Klijn JG, Meijers-Heijboer H, Foekens JA, Schutte M (2009) CHEK2 1100delC and male breast cancer in the Netherlands. Breast Cancer Res Treat 116(2):397\u2013400. https:\/\/doi.org\/10.1007\/s10549-008-0162-7","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"4661_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomaki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KB, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King MC, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497\u2013506. https:\/\/doi.org\/10.1056\/NEJMoa1400382","journal-title":"N Engl J Med"},{"issue":"3","key":"4661_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jmg.38.3.159","volume":"38","author":"JD Fackenthal","year":"2001","unstructured":"Fackenthal JD, Marsh DJ, Richardson AL, Cummings SA, Eng C, Robinson BG, Olopade OI (2001) Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 38(3):159\u2013164","journal-title":"J Med Genet"},{"issue":"1","key":"4661_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1897-4287-12-5","volume":"12","author":"KC Lakshmaiah","year":"2014","unstructured":"Lakshmaiah KC, Kumar AN, Purohit S, Viveka BK, Rajan KR, Zameer MAL, Namitha P, Saini ML, Azim HA Jr, Saini KS (2014) Neurofibromatosis type I with breast cancer: not only for women! Hered Cancer Clin Pract 12(1):5. https:\/\/doi.org\/10.1186\/1897-4287-12-5","journal-title":"Hered Cancer Clin Pract"},{"issue":"19","key":"4661_CR12","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","volume":"32","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, McGuire V, Ladabaum U, Kobayashi Y, Lincoln SE, Cargill M, Ford JM (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32(19):2001\u20132009. https:\/\/doi.org\/10.1200\/JCO.2013.53.6607","journal-title":"J Clin Oncol"},{"issue":"1","key":"4661_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, Timms K, Garber JE, Herold C, Ellisen L, Krejdovsky J, DeLeonardis K, Sedgwick K, Soltis K, Roa B, Wenstrup RJ, Hartman AR (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121(1):25\u201333. https:\/\/doi.org\/10.1002\/cncr.29010","journal-title":"Cancer"},{"issue":"10","key":"4661_CR14","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1245\/s10434-015-4754-2","volume":"22","author":"NS Kapoor","year":"2015","unstructured":"Kapoor NS, Curcio LD, Blakemore CA, Bremner AK, McFarland RE, West JG, Banks KC (2015) Multigene panel testing detects equal rates of pathogenic BRCA1\/2 mutations and has a higher diagnostic yield compared to limited BRCA1\/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Oncol 22(10):3282\u20133288. https:\/\/doi.org\/10.1245\/s10434-015-4754-2","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"4661_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","volume":"1","author":"A Desmond","year":"2015","unstructured":"Desmond A, Kurian AW, Gabree M, Mills MA, Anderson MJ, Kobayashi Y, Horick N, Yang S, Shannon KM, Tung N, Ford JM, Lincoln SE, Ellisen LW (2015) Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol 1(7):943\u2013951. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2690","journal-title":"JAMA Oncol"},{"issue":"3","key":"4661_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10549-016-4085-4","volume":"161","author":"M Pritzlaff","year":"2017","unstructured":"Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS, Goldgar DE, Shimelis H, Couch FJ, Chao EC, LaDuca H (2017) Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat 161(3):575\u2013586. https:\/\/doi.org\/10.1007\/s10549-016-4085-4","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"4661_CR17","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16(3):1215","journal-title":"Nucl Acids Res"},{"issue":"5","key":"4661_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"1","key":"4661_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13058-016-0671-y","volume":"18","author":"V Silvestri","year":"2016","unstructured":"Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, Nussbaum RL, Olopade OI, Rantala J, Yoon SY, Caligo MA, Spugnesi L, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Toland AE, Senter L, Andrulis IL, Glendon G, Hulick PJ, Imyanitov EN, Greene MH, Mai PL, Singer CF, Rappaport-Fuerhauser C, Kramer G, Vijai J, Offit K, Robson M, Lincoln A, Jacobs L, Machackova E, Foretova L, Navratilova M, Vasickova P, Couch FJ, Hallberg E, Ruddy KJ, Sharma P, Kim SW, kConFab I, Teixeira MR, Pinto P, Montagna M, Matricardi L, Arason A, Johannsson OT, Barkardottir RB, Jakubowska A, Lubinski J, Izquierdo A, Pujana MA, Balmana J, Diez O, Ivady G, Papp J, Olah E, Kwong A, Hereditary B, Ovarian Cancer Research Group N, Nevanlinna H, Aittomaki K, Perez Segura P, Caldes T, Van Maerken T, Poppe B, Claes KB, Isaacs C, Elan C, Lasset C, Stoppa-Lyonnet D, Barjhoux L, Belotti M, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Hahnen E, Kast K, Arnold N, Varon-Mateeva R, Wand D, Godwin AK, Evans DG, Frost D, Perkins J, Adlard J, Izatt L, Platte R, Eeles R, Ellis S, Embrace Hamann U, Garber J, Fostira F, Fountzilas G, Pasini B, Giannini G, Rizzolo P, Russo A, Cortesi L, Papi L, Varesco L, Palli D, Zanna I, Savarese A, Radice P, Manoukian S, Peissel B, Barile M, Bonanni B, Viel A, Pensotti V, Tommasi S, Peterlongo P, Weitzel JN, Osorio A, Benitez J, McGuffog L, Healey S, Gerdes AM, Ejlertsen B, Hansen TV, Steele L, Ding YC, Tung N, Janavicius R, Goldgar DE, Buys SS, Daly MB, Bane A, Terry MB, John EM, Southey M, Easton DF, Chenevix-Trench G, Antoniou AC, Ottini L (2016) Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1\/2. Breast Cancer Res 18(1):15. https:\/\/doi.org\/10.1186\/s13058-016-0671-y","journal-title":"Breast Cancer Res"},{"issue":"8","key":"4661_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L, Vaccari EM, Bissonnette J, Booker JK, Cremona ML, Gibellini F, Murphy PD, Pineda-Alvarez DE, Pollevick GD, Xu Z, Richard G, Bale S, Klein RT, Hruska KS, Chung WK (2016) Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med 18(8):823\u2013832. https:\/\/doi.org\/10.1038\/gim.2015.166","journal-title":"Genet Med"},{"issue":"6","key":"4661_CR21","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480\u20131490. https:\/\/doi.org\/10.1200\/JCO.2002.20.6.1480","journal-title":"J Clin Oncol"},{"issue":"1","key":"4661_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10549-012-2062-0","volume":"134","author":"L Ottini","year":"2012","unstructured":"Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M, Peterlongo P, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D (2012) Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy. Breast Cancer Res Treat 134(1):411\u2013418. https:\/\/doi.org\/10.1007\/s10549-012-2062-0","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4661_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cge.12274","volume":"85","author":"I Konstantopoulou","year":"2014","unstructured":"Konstantopoulou I, Tsitlaidou M, Fostira F, Pertesi M, Stavropoulou AV, Triantafyllidou O, Tsotra E, Tsiftsoglou AP, Tsionou C, Droufakou S, Dimitrakakis C, Fountzilas G, Yannoukakos D (2014) High prevalence of BRCA1 founder mutations in Greek breast\/ovarian families. Clin Genet 85(1):36\u201342. https:\/\/doi.org\/10.1111\/cge.12274","journal-title":"Clin Genet"},{"issue":"1","key":"4661_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10549-012-2021-9","volume":"134","author":"F Fostira","year":"2012","unstructured":"Fostira F, Tsitlaidou M, Papadimitriou C, Pertesi M, Timotheadou E, Stavropoulou AV, Glentis S, Bournakis E, Bobos M, Pectasides D, Papakostas P, Pentheroudakis G, Gogas H, Skarlos P, Samantas E, Bafaloukos D, Kosmidis PA, Koutras A, Yannoukakos D, Konstantopoulou I, Fountzilas G (2012) Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study. Breast Cancer Res Treat 134(1):353\u2013362. https:\/\/doi.org\/10.1007\/s10549-012-2021-9","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"4661_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1593\/neo.04193","volume":"6","author":"K Syrjakoski","year":"2004","unstructured":"Syrjakoski K, Kuukasjarvi T, Waltering K, Haraldsson K, Auvinen A, Borg A, Kainu T, Kallioniemi OP, Koivisto PA (2004) BRCA2 mutations in 154 finnish male breast cancer patients. Neoplasia 6(5):541\u2013545. https:\/\/doi.org\/10.1593\/neo.04193","journal-title":"Neoplasia"},{"issue":"8","key":"4661_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ng1837","volume":"38","author":"A Renwick","year":"2006","unstructured":"Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility C, Easton DF, Stratton MR, Rahman N (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873\u2013875. https:\/\/doi.org\/10.1038\/ng1837","journal-title":"Nat Genet"},{"issue":"9","key":"4661_CR27","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, Feng B, McFarland R, Pesaran T, Huether R, LaDuca H, Chao EC, Goldgar DE, Dolinsky JS (2017) Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol 3(9):1190\u20131196. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424","journal-title":"JAMA Oncol"},{"issue":"1","key":"4661_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","volume":"2","author":"NJ Roberts","year":"2012","unstructured":"Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, Gallinger S, Schwartz AG, Syngal S, Cote ML, Axilbund J, Schulick R, Ali SZ, Eshleman JR, Velculescu VE, Goggins M, Vogelstein B, Papadopoulos N, Hruban RH, Kinzler KW, Klein AP (2012) ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2(1):41\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0194","journal-title":"Cancer Discov"},{"issue":"2","key":"4661_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ygyno.2017.08.030","volume":"147","author":"J Lilyquist","year":"2017","unstructured":"Lilyquist J, LaDuca H, Polley E, Davis BT, Shimelis H, Hu C, Hart SN, Dolinsky JS, Couch FJ, Goldgar DE (2017) Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls. Gynecol Oncol 147(2):375\u2013380. https:\/\/doi.org\/10.1016\/j.ygyno.2017.08.030","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4661_CR30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1086\/341943","volume":"71","author":"P Vahteristo","year":"2002","unstructured":"Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71(2):432\u2013438. https:\/\/doi.org\/10.1086\/341943","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4661_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12885-017-3631-8","volume":"17","author":"S Hallamies","year":"2017","unstructured":"Hallamies S, Pelttari LM, Poikonen-Saksela P, Jekunen A, Jukkola-Vuorinen A, Auvinen P, Blomqvist C, Aittomaki K, Mattson J, Nevanlinna H (2017) CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population. BMC Cancer 17(1):620. https:\/\/doi.org\/10.1186\/s12885-017-3631-8","journal-title":"BMC Cancer"},{"issue":"4","key":"4661_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cancergen.2015.02.006","volume":"208","author":"P Apostolou","year":"2015","unstructured":"Apostolou P, Fostira F, Papamentzelopoulou M, Michelli M, Panopoulos C, Fountzilas G, Konstantopoulou I, Voutsinas GE, Yannoukakos D (2015) CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases. Cancer Genet 208(4):129\u2013134. https:\/\/doi.org\/10.1016\/j.cancergen.2015.02.006","journal-title":"Cancer Genet"},{"issue":"4","key":"4661_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/cge.12842","volume":"90","author":"P Zemankova","year":"2016","unstructured":"Zemankova P, Lhota F, Kleiblova P, Soukupova J, Vocka M, Janatova M, Kleibl Z (2016) RE: frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk. Clin Genet 90(4):387\u2013389. https:\/\/doi.org\/10.1111\/cge.12842","journal-title":"Clin Genet"},{"issue":"4","key":"4661_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/cge.12837","volume":"90","author":"K Pfeifer","year":"2016","unstructured":"Pfeifer K, Schurmann P, Bogdanova N, Neuhauser K, Kostovska IM, Plaseska-Karanfilska D, Park-Simon TW, Schindler D, Dork T (2016) Frameshift variant FANCL*c.1096_1099dupATTA is not associated with high breast cancer risk. Clin Genet 90(4):385\u2013386. https:\/\/doi.org\/10.1111\/cge.12837","journal-title":"Clin Genet"},{"issue":"4","key":"4661_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","volume":"10","author":"CS Richards","year":"2008","unstructured":"Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE, Molecular Subcommittee of the ALQAC (2008) ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med 10(4):294\u2013300. https:\/\/doi.org\/10.1097\/gim.0b013e31816b5cae","journal-title":"Genet Med"},{"issue":"4","key":"4661_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1200\/JCO.2014.57.8088","volume":"33","author":"SW Broeke ten","year":"2015","unstructured":"ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I, Capella Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TG, Menko FH, Lindblom A, Mensenkamp AR, Moller P, van Os TA, Rahner N, Redeker BJ, Sijmons RH, Spruijt L, Suerink M, Vos YJ, Wagner A, Hes FJ, Vasen HF, Nielsen M, Wijnen JT (2015) Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. J Clin Oncol 33(4):319\u2013325. https:\/\/doi.org\/10.1200\/JCO.2014.57.8088","journal-title":"J Clin Oncol"},{"issue":"22","key":"4661_CR37","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1200\/JCO.2016.71.9260","volume":"35","author":"CR Espenschied","year":"2017","unstructured":"Espenschied CR, LaDuca H, Li S, McFarland R, Gau CL, Hampel H (2017) Multigene panel testing provides a new perspective on lynch syndrome. J Clin Oncol 35(22):2568\u20132575. https:\/\/doi.org\/10.1200\/JCO.2016.71.9260","journal-title":"J Clin Oncol"},{"issue":"22","key":"4661_CR38","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Guimbaud R, Buecher B, Bignon YJ, Caron O, Colas C, Nogues C, Lejeune-Dumoulin S, Olivier-Faivre L, Polycarpe-Osaer F, Nguyen TD, Desseigne F, Saurin JC, Berthet P, Leroux D, Duffour J, Manouvrier S, Frebourg T, Sobol H, Lasset C, Bonaiti-Pellie C, French Cancer Genetics N (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305(22):2304\u20132310. https:\/\/doi.org\/10.1001\/jama.2011.743","journal-title":"JAMA"},{"issue":"2","key":"4661_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","volume":"135","author":"L Senter","year":"2008","unstructured":"Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135(2):419\u2013428. https:\/\/doi.org\/10.1053\/j.gastro.2008.04.026","journal-title":"Gastroenterology"},{"issue":"3","key":"4661_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10549-010-1195-2","volume":"126","author":"YC Ding","year":"2011","unstructured":"Ding YC, Steele L, Kuan CJ, Greilac S, Neuhausen SL (2011) Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat 126(3):771\u2013778. https:\/\/doi.org\/10.1007\/s10549-010-1195-2","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4661-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4661-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4661-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T15:31:31Z","timestamp":1660318291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4661-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4661"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4661-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]},"assertion":[{"value":"26 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no disclosures\/conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}